Medindia

X

FDA Classifies Prolia(TM) (Denosumab) Complete Response Submission and Targets Action Date

Saturday, February 20, 2010 General News J E 4
Advertisement

CONTACT:

Sarah Reines: (805) 447-9783 (media, osteoporosis)

Arvind Sood: (805) 447-4261 (investors)

Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Upcoming Webinar to Inform Public About Access to ...
S
Cunard's Queen Victoria is 'Pretty in Pink' in Syd...